loading animation for AJAX calls

176 Reports in Pharmaceuticals

Active Pharmaceutical Ingredients: Global Markets to 2022

Published - Jul 2018 | Analyst - BCC Research Staff| Code - PHM200A

The global active pharmaceutical ingredient (API) market should reach $154.7 billion by 2022 from $114.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.2% for the period 2017-2022.

Neuroprotective Agents: Therapeutic Applications and Global Marke...

Published - Jul 2018 | Analyst - Ufuk Ezer| Code - PHM188A

The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.

Antiulcerant Drugs: Global Markets to 2022

Published - Jun 2018 | Analyst - BCC Research Reference Staff| Code - PHM202A

The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.

Clinical Nutrition: Global Markets to 2022

Published - May 2018 | Analyst - BCC Research Staff| Code - PHM198A

The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.

The Global Influenza Market

Published - May 2018 | Analyst - Melissa Elder| Code - PHM049E

The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...

Published - May 2018 | Analyst - Usha Nagavarapu| Code - PHM153B

The global market for circulating tumor cell technology will grow from nearly $4.6 billion in 2017 to around $10.3 billion by 2022 with a compound annual growth rate (CAGR) of 17.6% for the period of 2017-2022.

Excipients in Pharmaceuticals: Global Markets to 2022

Published - May 2018 | Analyst - BCC Research Staff| Code - PHM010K

The global market for pharmaceutical excipients will grow from nearly $6.8 billion in 2017 to $8.7 billion by 2022 with a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.

Drugs for Urinary Incontinence and Overactive Bladder: Global Mar...

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM199A

The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.

Muscle Relaxants: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM196A

The global muscle relaxants market totaled $18.4 billion in 2017 and is estimated to reach $24.4 billion by 2022, growing at a compound annual growth rate (CAGR) of 5.8% for the period of 2017-2022. 

Anti-Epileptic Drugs: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM197A

The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.

Drugs for Infertility: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM194A

The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.

Global Markets for Vaccine Technologies

Published - Apr 2018 | Analyst - Anuj Pathak| Code - PHM014G

The global market for vaccine technologies reached $35.7 billion in 2017 and should reach nearly $46.6 billion by 2022, at a compound annual growth rate (CAGR) of 5.5% for the period of 2017-2022.

Cardiovascular Drugs: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Staff| Code - PHM191A

The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.

Small Molecule Therapies for Rheumatoid Arthritis: Global Markets...

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM195A

The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.

Global Markets for Contract Pharmaceutical Manufacturing, Researc...

Published - Apr 2018 | Analyst - Shalini Shahani Dewan| Code - PHM043G

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $136.4 billion in 2017 to $197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Anti-Parkinson's Drugs: Global Markets to 2022

Published - Apr 2018 | Analyst - BCC Research Reference Staff| Code - PHM193A

The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.

Global Markets for Infectious Disease Treatments

Published - Mar 2018 | Analyst - Megha Joshi-Sood| Code - PHM061D

The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...

Published - Dec 2017 | Analyst - Paul Taylor| Code - PHM177A

The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.

Medication Adherence: Systems, Technologies and Global Markets

Published - Nov 2017 | Analyst - Dr. Ritu Thakur Dangi| Code - PHM182A

The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.

Substance Abuse and Addiction Treatment, Global Markets to 2021

Published - Aug 2017 | Analyst - Yojana Jeevane| Code - PHM035C

The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.

Antibody Drug Conjugates: Technologies and Global Markets

Published - Jun 2017 | Analyst - Shalini Shahani Dewan| Code - PHM161B

The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.

The Chinese Market for Cancer Intervention

Published - Jun 2017 | Analyst - Jason Chen| Code - PHM179A

The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022.

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2017 | Analyst - Vijay Laxmi| Code - PHM026C

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Global Markets for Neglected Tropical Disease Treatments

Published - Jun 2017 | Analyst - Megha Joshi-Sood| Code - PHM180A

The global market for neglected tropical diseases should reach $2.6 billion by 2021 from $1.4 billion in 2016 at a compound annual growth rate (CAGR) of 14.1%, from 2016 to 2021.

Drug Testing: Technologies and Global Markets

Published - May 2017 | Analyst - Jon Evans| Code - PHM013G

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.

« 1 2 3 4 5 »

6 Upcoming Reports in Pharmaceuticals

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question

Target Date - May 2019| Author - Dr. Cheryl Lee Barton| Code - PHM212A| Price - $995

Report Includes

  • An introduction to interleukin-2 (IL-2) and identification of its applications
  • Insights of the latest trends and technologies in the IL-2 research and development
  • Discussion of strategies adopted by IL-2 developers for the successful treatment of cancer and information on NKTR-214, a Nektar Therapeutics product
  • Review of recent VC investment in this zone highlighted by Syncona and Novartis Venture Fund recent CHF35m investment in Anaveon AG, a new Swiss Biotech company spun out from the University of Zuirich which is developing a novel oncologic monoclonal antibody that boosts IL-2 but has an improved side-effect profile.
  • Detailed description of autoimmune responses and possible ways to augment immune responses so as to improve antitumor activity and reduce off target effect
  • An understanding of various conditions which may develop as an off-target effects in the cancer treatment such as metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), and Type 1 diabetes (T1D)

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM